![Actinomycosis mimicking malignancy](https://sbmt.org.br/wp-content/uploads/2024/07/img-05.jpg)
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
14/07/2022
**Esta reportagem reflete exclusivamente a opinião do entrevistado.**